ARDT•prnewswire•
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Summary
SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2025 by prnewswire